Medical University of Vienna

Medical University of Vienna logo
🇦🇹Austria
Ownership
Private
Established
1365-01-01
Employees
1K
Market Cap
-
Website
http://www.meduniwien.ac.at

Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration

Phase 4
Completed
Conditions
First Posted Date
2006-01-23
Last Posted Date
2010-08-04
Lead Sponsor
Medical University of Vienna
Target Recruit Count
20
Registration Number
NCT00280514
Locations
🇦🇹

Medical University Vienna, Vienna, Austria

Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions

First Posted Date
2006-01-23
Last Posted Date
2008-07-09
Lead Sponsor
Medical University of Vienna
Target Recruit Count
21
Registration Number
NCT00280501
Locations
🇦🇹

Department of Clinical Pharmacology, Vienna, Austria

Choroidal Blood Flow Regulation During Isometric Exercise: Effects of Ca2+-Channel Blockade

First Posted Date
2006-01-23
Last Posted Date
2008-07-09
Lead Sponsor
Medical University of Vienna
Target Recruit Count
21
Registration Number
NCT00280462
Locations
🇦🇹

Department of Clinical Pharmacology, Vienna, Austria

Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2006-01-20
Last Posted Date
2010-04-22
Lead Sponsor
Medical University of Vienna
Target Recruit Count
32
Registration Number
NCT00280007
Locations
🇦🇹

Medizinische Universität Wien, Vienna, Austria

Effects of Intravenous Clonidine on Ocular Blood Flow and Intraocular Pressure

Phase 4
Completed
Conditions
First Posted Date
2006-01-19
Last Posted Date
2006-01-19
Lead Sponsor
Medical University of Vienna
Target Recruit Count
12
Registration Number
NCT00279253

Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers

Not Applicable
Completed
Conditions
First Posted Date
2006-01-12
Last Posted Date
2007-02-12
Lead Sponsor
Medical University of Vienna
Target Recruit Count
12
Registration Number
NCT00275730
Locations
🇦🇹

Department of Clinical Pharmacology, Vienna, Austria

Treatment of Chronic GVHD of Liver or Lungs by ECP

First Posted Date
2006-01-04
Last Posted Date
2006-01-04
Lead Sponsor
Medical University of Vienna
Target Recruit Count
20
Registration Number
NCT00271869
Locations
🇦🇹

Medical University of Vienna, Department of Medicine I, BMT, Vienna, Austria

Recombinant Human Superoxide Dismutase (rhSOD) and Vascular Reactivity

Phase 1
Completed
Conditions
First Posted Date
2005-12-12
Last Posted Date
2008-05-22
Lead Sponsor
Medical University of Vienna
Target Recruit Count
43
Registration Number
NCT00264186
Locations
🇦🇹

Medical University of Vienna - General Hospital of the City of Vienna AKH, Vienna, Austria

Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma

Phase 2
Conditions
First Posted Date
2005-12-05
Last Posted Date
2006-10-18
Lead Sponsor
Medical University of Vienna
Target Recruit Count
16
Registration Number
NCT00261612
Locations
🇦🇹

Medical University Vienna, Dept. of Medicine I, Clinical Division of Oncology, Vienna, Austria

© Copyright 2024. All Rights Reserved by MedPath